Late relapse after CAR-T cell therapy for adult patients with hematologic malignancies: A definite evidence from systematic review and meta-analysis on individual data

• Main Authors: Alessia Zinzi (Author), Mario Gaio (Author), Valerio Liguori (Author), Cecilia Cagnotta (Author), Donatella Paolino (Author), Giuseppe Paolisso (Author), Giuseppe Castaldo (Author), Giovanni Francesco Nicoletti (Author), Francesco Rossi (Author), Annalisa Capuano (Author), Concetta Rafaniello (Author)
• Format: Book
• Published: Elsevier, 2023-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Chimeric Antigen Receptor (CAR)-modified T lymphocytes represent one of the most innovative and promising approaches to treating hematologic malignancies. CAR-T cell therapy is currently being used for the treatment of relapsed/refractory (r/r) B-cell malignancies including Acute Lymphoblastic Leuke...